9^th World Dermatology, Trichology and Aesthetic Congress

Dermatological Oncology

Submit Abstract Register Now

It is estimated that 1 in 52 men and 1 in 77 women in the US will be diagnosed with melanoma in their lifetime. Despite the fact that melanoma is one of the most rapidly increasing forms of human cancer, new treatments have been slow in developing and the mortality rate continues to rise. We now know that there are several well-defined risk factors for this form of cancer. Our report contains quantitative and qualitative analytical content, covering the present and future of the global cancer drugs market. Although our report is market-centered, we include medical and technical information. We include analyses of under-met market needs from the present looking forward.

GMR Data forecast that Avastin will reach its financial peak by 2018 before losing its patent exclusivity in 2019. The drug is also set to benefit from a potential combination therapy, with EGFL7, for the treatment of colorectal and lung cancer, similar to that of Herceptin and Perjeta.